icon- folder.gif   Conference Reports for NATAP  
 
  13th IAS Conference on HIV Science
IAS 2026
July 26-31 Rio, Brazil
 Back grey_arrow_rt.gif
 
 
 
PURPOSE: Experiences with Twice-Yearly Lenacapavir for PrEP in the PURPOSE 1 pen-Label Expension Phase
 
 
  IAS 2026 Rio, Brazil
 

0729261copy

0729262copy

0729263copy

0729264copy

0729265copy

0729266copy